These certificates confirm identity, purity and potency parameters according to scientific standards, so researchers can maintain proper experimental records
In families of patients with PA (pernicious anaemia), ulcerative colitis, rheumatoid arthritis, polymyalgia, psoriasis, sarcoidosis, lupus were in one study more common than in those of people without PA
AOD-9604 (Anti-Obesity Drug 9604) Description: A fat-burning peptide that stimulates the breakdown of stored fat while preventing new fat deposits, mimicking the fat-loss effects of growth hormone
Cognitive function and memory may show marked improvement
Pickart L, Margolina A Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Quick AOD-9604 Dosing Summary AOD-9604 is a growth hormone fragment peptide administered via subcutaneous injection, typically dosed at 250-500 mcg daily in a fasted state